MONTREAL, June 26 /CNW Telbec/ - Quebec is the first province in Canada
to add Orencia to its list of reimbursed medications to treat rheumatoid
arthritis. Bristol-Myers Squibb Canada is happy to announce today that
Orencia(R) (abatacept), the first in a new class of biologic agents for
rheumatoid arthritis (RA) will be reimbursed by the Régime général d'assurance
médicaments du Québec.
